Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology - 03/02/23
, Kefeng Wang a, ⁎ 
Abstract |
N6-methyladenosine (m6A), as the most abundant and well-known RNA modification, has been found to play an important role in cancer. Circular RNAs (circRNAs) are a class of single-stranded covalently closed RNA molecules generated by the reverse splicing process. Recent studies have revealed the vital roles of circRNAs in many diseases, including tumorigenesis. Accumulating evidence also shows an association between m6A modification and circRNAs. This study aimed to review the interactions between m6A modification and circRNAs and illustrate their roles in tumorigenesis. m6A modification can modulate the biogenesis, translation, cytoplasmic export, degradation, and other functions of circRNAs in different tumors. circRNAs can also modulate m6A modification by affecting writers, erasers, and readers. We focused on the potential regulatory mechanisms and the biological consequences of m6A modification of circRNAs, as well as the interactions in tumors of different systems. Finally, we listed the possible development directions of m6A modification and circRNAs, which might facilitate the clinical application of tumor therapy.
Availability of data and materials |
Not applicable.
Keywords
Le texte complet de cet article est disponible en PDF.Highlights |
• | m6A modification could play an important role in the field of oncology. |
• | The regulatory mechanisms and biological functions of m6A modification of circRNAs. |
• | The possible development directions of m6A modification and circRNAs in tumor therapy. |
Keywords : Cancer, Circular RNA, m6A, N6-methyladenosine, Therapy
Abbreviations : m6A, circRNAs, m5C, m1A, mRNAs, ncRNAs, miRNAs, rRNAs, lncRNAs, snRNAs, MTC, METTL3, METTL14, RBM15, WTAP, ZC3H13, ZCCHC4, 3′ -UTR, APA, CDK1, FTO, ALKBH5, GC, BC, BCa, CC, RBPs, YTH, HNRNPs, IGF2BP1/2/3, HNRNPA2B1, eIF3, CRC, HCC, Bcl-2, VEGF, IL, AML, mTOR, ASB2, RARA, ATRA, EMT, NPC, TME, SOCS2, DC, MRE, ORF, IRES, NSCLC, ZEB1, CSCs, BCSCs, TKI, CML, HPSCC, SCC, LCC, OS, TNFAIP3, ATG16L1, HPV, ceRNA, NANOG, TMZ
Plan
Vol 159
Article 114260- mars 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
